123 related articles for article (PubMed ID: 11398611)
61. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
62. Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma.
Blinde SE; Schasfoort R; Mens JW; Verhoef C; Olofsen M; Nuyttens JJ
Dis Colon Rectum; 2014 May; 57(5):578-84. PubMed ID: 24819097
[TBL] [Abstract][Full Text] [Related]
63. PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.
Zimmermann M; Beer J; Bodis S; von Moos R; Vlachopoulou V; Zwahlen DR; Oehler C
Acta Oncol; 2017 Dec; 56(12):1734-1740. PubMed ID: 28557585
[TBL] [Abstract][Full Text] [Related]
64. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
[TBL] [Abstract][Full Text] [Related]
65. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison.
Allal A; Kurtz JM; Pipard G; Marti MC; Miralbell R; Popowski Y; Egeli R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):59-66. PubMed ID: 8365944
[TBL] [Abstract][Full Text] [Related]
66. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience.
Sandhu AP; Symonds RP; Robertson AG; Reed NS; McNee SG; Paul J
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):575-81. PubMed ID: 9486607
[TBL] [Abstract][Full Text] [Related]
67. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
[TBL] [Abstract][Full Text] [Related]
68. Chemoradiotherapy of anal carcinoma: tumour response and acute toxicity.
Tanum G; Tveit KM; Karlsen KO
Oncology; 1993; 50(1):14-7. PubMed ID: 8421594
[TBL] [Abstract][Full Text] [Related]
69. Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
Franco P; De Bari B; Arcadipane F; Lepinoy A; Ceccarelli M; Furfaro G; Mistrangelo M; Cassoni P; Valgiusti M; Passardi A; Casadei Gardini A; Trino E; Martini S; Iorio GC; Evangelista A; Ricardi U; Créhange G
Radiat Oncol; 2018 Sep; 13(1):172. PubMed ID: 30201015
[TBL] [Abstract][Full Text] [Related]
70. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
71. Mitomycin in anal canal carcinoma.
Cummings BJ; Keane TJ; O'Sullivan B; Wong CS; Catton CN
Oncology; 1993 Apr; 50 Suppl 1():63-9. PubMed ID: 8483559
[TBL] [Abstract][Full Text] [Related]
72. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.
Wong CS; Tsao MS; Sharma V; Chapman WB; Pintilie M; Cummings BJ
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):309-14. PubMed ID: 10487550
[TBL] [Abstract][Full Text] [Related]
73. Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
Doyen J; Benezery K; Follana P; Ortholan C; Gérard JP; Hannoun-Levi JM; Gal J; Francois E
Dis Colon Rectum; 2013 Oct; 56(10):1125-33. PubMed ID: 24022529
[TBL] [Abstract][Full Text] [Related]
74. Cancer of the anal canal: treatment with chemotherapy and low-dose radiation therapy.
Smith DE; Shah KH; Rao AR; Frost DB; Latino F; Anderson PJ; Peddada AV; Kagan AR
Radiology; 1994 May; 191(2):569-72. PubMed ID: 8153343
[TBL] [Abstract][Full Text] [Related]
75. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy.
Cummings B; Keane T; Thomas G; Harwood A; Rider W
Cancer; 1984 Nov; 54(10):2062-8. PubMed ID: 6435851
[TBL] [Abstract][Full Text] [Related]
76. A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anus.
Ngan D; Chu J; Chander S; Michael M; Heriot AG; Ngan SY; Rischin D; Leong T
Asia Pac J Clin Oncol; 2019 Feb; 15(1):75-81. PubMed ID: 30536770
[TBL] [Abstract][Full Text] [Related]
77. [Carcinoma of the anal canal--results of radical radiotherapy].
Radosević-Jelić Lj; Stojanović S; Durbaba M; Josifovski J; Krivokapić Z
Acta Chir Iugosl; 2002; 49(2):79-83. PubMed ID: 12587476
[TBL] [Abstract][Full Text] [Related]
78. Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.
Tomasoa NB; Meulendijks D; Nijkamp J; Cats A; Dewit L
Acta Oncol; 2016 Jun; 55(6):760-6. PubMed ID: 26878244
[TBL] [Abstract][Full Text] [Related]
79. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
[TBL] [Abstract][Full Text] [Related]
80. Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study.
Vuong T; Devic S; Belliveau P; Muanza T; Hegyi G
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):823-31. PubMed ID: 12788191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]